{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:20:36Z","timestamp":1785457236930,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to evaluate the clinical and dosimetric factors predictive of acute anal toxicity (AAT) after radiotherapy in prostate cancer (PCa) patients with or without hemorrhoids.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed data from 347 PCa patients (248 cases treated from July 2013 to November 2017 for training cohort and 99 cases treated in 2018 for validation cohort) treated with pelvic radiotherapy at a single institution. Anal canal dose\u2013volume histogram was used to determine the prescribed dose. Univariate and multivariate analyses were used to evaluate the risk of AAT as a function of clinical and dosimetric factors.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Totally, 39.5% (98\/248) and 31.3% (31\/99) of the PCa patients developed AAT in training and validation cohorts, respectively. The incidence of AAT was much higher in patients with hemorrhoids than in those without hemorrhoids in both training and validation cohorts. Hemorrhoids and volume received more than 20\u2009Gy (V20) were valuated as independent factors for predicting AAT in training cohort. Similar results were also observed in our validation cohort. The combination of hemorrhoids and high anal canal V20 (&gt;\u200974.93% as determined by ROC curves) showed the highest specificity and positive predictive values for predicting AAT in both training and validation cohorts.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>AAT occurs commonly in PCa patients with hemorrhoids during and after pelvic radiotherapy. Hemorrhoids and anal canal V20 are independent predictors of AAT. These factors should be carefully considered during treatment planning to minimize the incidence of AAT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-019-1374-1","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T10:27:33Z","timestamp":1570703253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Xingsi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaonan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"issue":"6","key":"1374_CR1","first-page":"394","volume":"68","author":"Freddie Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"1374_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/aja.2008.15","volume":"11","author":"Y-P Zhu","year":"2008","unstructured":"Zhu Y-P, Ye D-W, Yao X-D, Zhang S-L, Dai B, Zhang H-L, Shen Y-J, Zhu Y, Shi G-H. Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries. Asian J Androl. 2008;11(1):104\u20138.","journal-title":"Asian J Androl"},{"issue":"4","key":"1374_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3322\/canjclin.57.4.190","volume":"57","author":"M McCracken","year":"2007","unstructured":"McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, Deapen D, Ward E. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57(4):190\u2013205.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1374_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ejca.2004.12.033","volume":"41","author":"HG Sim","year":"2005","unstructured":"Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer. 2005;41(6):834\u201345.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1374_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.eururo.2011.07.003","volume":"60","author":"KD Linton","year":"2011","unstructured":"Linton KD, Catto JW. Gastrointestinal toxicity following radiotherapy for prostate cancer: a ring of fire. Eur Urol. 2011;60(5):917\u20139.","journal-title":"Eur Urol"},{"issue":"3","key":"1374_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrurol.2015.27","volume":"12","author":"R Kelsey","year":"2015","unstructured":"Kelsey R. Prostate cancer: Hypofractionation not associated with reduced toxicity. Nat Rev Urol. 2015;12(3):126.","journal-title":"Nat Rev Urol"},{"issue":"7","key":"1374_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/cncr.29148","volume":"121","author":"P Fang","year":"2015","unstructured":"Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer. 2015;121(7):1118\u201327.","journal-title":"Cancer"},{"issue":"2","key":"1374_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.radonc.2018.03.032","volume":"128","author":"R Krol","year":"2018","unstructured":"Krol R, McColl GM, Hopman WPM, Smeenk RJ. Anal and rectal function after intensity-modulated prostate radiotherapy with endorectal balloon. Radiother Oncol. 2018;128(2):364\u20138.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1374_CR9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ijrobp.2011.08.007","volume":"83","author":"RJ Smeenk","year":"2012","unstructured":"Smeenk RJ, Hoffmann AL, Hopman WP, van Lin EN, Kaanders JH. Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(2):636\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1374_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/gut.43.1.123","volume":"43","author":"EK Yeoh","year":"1998","unstructured":"Yeoh EK, Russo A, Botten R, Fraser R, Roos D, Penniment M, Borg M, Sun WM. Acute effects of therapeutic irradiation for prostatic carcinoma on anorectal function. Gut. 1998;43(1):123\u20137.","journal-title":"Gut"},{"issue":"1","key":"1374_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5301\/tj.5000219","volume":"101","author":"H Jang","year":"2015","unstructured":"Jang H, Baek JG, Jo S. The anal canal as a risk organ in cervical cancer patients with hemorrhoids undergoing whole pelvic radiotherapy. Tumori. 2015;101(1):72\u20137.","journal-title":"Tumori"},{"issue":"1050","key":"1374_CR12","doi-asserted-by":"publisher","first-page":"20150022","DOI":"10.1259\/bjr.20150022","volume":"88","author":"H Jang","year":"2015","unstructured":"Jang H, Baek JG, Yoo SJ. Acute anal toxicity after whole pelvic radiotherapy in patients with asymptomatic haemorrhoids: identification of dosimetric and patient factors. Br J Radiol. 2015;88(1050):20150022.","journal-title":"Br J Radiol"},{"issue":"19","key":"1374_CR13","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3748\/wjg.v17.i19.2431","volume":"17","author":"MY Su","year":"2011","unstructured":"Su MY, Chiu CT, Lin WP, Hsu CM, Chen PC. Long-term outcome and efficacy of endoscopic hemorrhoid ligation for symptomatic internal hemorrhoids. World J Gastroenterol. 2011;17(19):2431\u20136.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1374_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0035-1568144","volume":"29","author":"Z Sun","year":"2016","unstructured":"Sun Z, Migaly J. Review of hemorrhoid disease: presentation and management. Clin Colon Rectal Surg. 2016;29(1):22\u20139.","journal-title":"Clin Colon Rectal Surg"},{"issue":"26","key":"1374_CR15","doi-asserted-by":"publisher","first-page":"e7309","DOI":"10.1097\/MD.0000000000007309","volume":"96","author":"G Lin","year":"2017","unstructured":"Lin G, Ge Q, He X, Qi H, Xu L. A novel technique for the treatment of stages III to IV hemorrhoids: homemade anal cushion suspension clamp combined with harmonic scalpel. Medicine (Baltimore). 2017;96(26):e7309.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1374_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96(5):644\u20137.","journal-title":"Acta Paediatr"},{"issue":"1","key":"1374_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.radonc.2009.05.014","volume":"93","author":"RJ Smeenk","year":"2009","unstructured":"Smeenk RJ, van Lin EN, van Kollenburg P, Kunze-Busch M, Kaanders JH. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy. Radiother Oncol. 2009;93(1):131\u20136.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1374_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2004.07.020","volume":"73","author":"PC Koper","year":"2004","unstructured":"Koper PC, Jansen P, van Putten W, van Os M, Wijnmaalen AJ, Lebesque JV, Levendag PC. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiother Oncol. 2004;73(1):1\u20139.","journal-title":"Radiother Oncol"},{"key":"1374_CR19","first-page":"167","volume":"6","author":"I Paydar","year":"2016","unstructured":"Paydar I, Cyr RA, Yung TM, Lei S, Collins BT, Chen LN, Suy S, Dritschilo A, Lynch JH, Collins SP. Proctitis 1 week after stereotactic body radiation therapy for prostate Cancer: implications for clinical trial design. Front Oncol. 2016;6:167.","journal-title":"Front Oncol"},{"issue":"3","key":"1374_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.radonc.2017.12.023","volume":"126","author":"EC Rijkmans","year":"2018","unstructured":"Rijkmans EC, van Triest B, Nout RA, Kerkhof EM, Buijsen J, Rozema T, Franssen JH, Velema LA, Laman MS, Cats A, et al. Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study. Radiother Oncol. 2018;126(3):417\u201323.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1374_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.radonc.2015.10.020","volume":"117","author":"RC Wortel","year":"2015","unstructured":"Wortel RC, Witte MG, van der Heide UA, Pos FJ, Lebesque JV, van Herk M, Incrocci L, Heemsbergen WD. Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer. Radiother Oncol. 2015;117(3):515\u201320.","journal-title":"Radiother Oncol"},{"issue":"4\u20135","key":"1374_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.canrad.2010.01.009","volume":"14","author":"MV Moreau-Claeys","year":"2010","unstructured":"Moreau-Claeys MV, Peiffert D. Normal tissue tolerance to external beam radiation therapy: anal canalCancer Radiother. 2010;14(4\u20135):359\u201362.","journal-title":"Cancer Radiother"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1374-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T23:14:08Z","timestamp":1602198848000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1374-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1374-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was approved by the Ethical Committee of Sun Yat-Sen University Cancer Center and informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}